From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Advanced Oncotherapy draws £2m second tranche from Blackfinch, Bracknor converts another £200k

By Nigel Somerville, the Deputy Sheriff of AIM | Wednesday 26 April 2017


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


At no-one-is-watching o’clock last night (5.48 pm) AIM-listed Advanced Oncotherapy (AVO) slipped out an announcement that it had drawn the £2m second tranche of cash available under its one-year loan deal with Blackfinch. With my maths suggesting that the company was close to running on fumes that extra £2m to keep the show on the road pro tem will come in handy.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Friday »

Tom

Sharestock: 1 ticket left!

Saturday »

So, Farewell then......

 

KEFI

Kefi: silence not a bad thing

 

TERN

Tern – open offer flop

 

GLEN

Still Good Value in Glencore?

Tuesday »

SOS

Sosandar – FY Results And An SOS

 

URU

URU – Stink Upon Stink

 

Gold

Turning gold digital?

Saturday »

OPTI

Optibiotix: where is the TR1?

Time left: 15:06:36